Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study

被引:5
|
作者
Ehrlich, Kristina [1 ]
Morbach, Caroline [2 ,3 ,4 ,5 ]
Reiter, Theresa [2 ]
Heuschmann, Peter Ulrich [6 ,7 ]
Hannemann, Anke [8 ,9 ]
Fassnacht, Martin [1 ,3 ,4 ]
Stoerk, Stefan [2 ,3 ,4 ]
Hahner, Stefanie [1 ]
Deutschbein, Timo [1 ,10 ]
机构
[1] Univ Wurzburg, Univ Hosp Wurzburg, Div Endocrinol & Diabet, Dept Internal Med 1, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Univ Hosp Wurzburg, Div Cardiol, Dept Internal Med 1, Wurzburg, Germany
[3] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany
[4] Univ Wurzburg, Univ Hosp Wurzburg, Wurzburg, Germany
[5] Univ Wurzburg, Univ Hosp Wurzburg, Acad Core Lab Ultrasound Based Cardiovasc Imaging, Wurzburg, Germany
[6] Univ Wurzburg, Univ Hosp Wurzburg, Clin Trial Ctr, Wurzburg, Germany
[7] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany
[8] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany
[9] Univ Med Greifswald, Partner Site Greifswald, German Ctr Cardiovasc Res DZHK, Greifswald, Germany
[10] Medicover Oldenburg MVZ, Oldenburg, Germany
关键词
Cardiac magnetic resonance imaging; Cardiovascular status; Cushing's syndrome; Echocardiography; Endogenous; Glucocorticoid excess; Hormones; Left ventricular hypertrophy; Metabolic profile; Quality of life; QUALITY-OF-LIFE; CORONARY-ARTERY-DISEASE; CUSHINGS-SYNDROME; RISK-FACTORS; ACTIVE DISEASE; MORTALITY; HEALTH; ATHEROSCLEROSIS; ECHOCARDIOGRAPHY; PERSISTENCE;
D O I
10.1186/s12902-020-00665-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Endogenous Cushing's syndrome (CS) results in increased cardiovascular (CV) morbidity and mortality. So far, most studies focussed on distinct disease entities rather than the integrity of the CV system. We here describe the design of the Cardiovascular Status in Endogenous Cortisol Excess Study (CV-CORT-EX), a study aiming to comprehensively investigate the health status of patients with endogenous CS (with a particular focus on CV phenotypes, biochemical aspects, quality of life, and psychosocial status). Method: A prospective non-interventional cohort study performed at a German tertiary referral centre. At the time of enrolment, patients will be categorised as: (1) newly diagnosed overt CS, (2) recurrent overt CS, (3) CS in remission, (4) presence of mild autonomous cortisol excess (MACE). The target cohorts will be n = 40 (groups 1 + 2), n = 80 (group 3), and n = 20 (group 4). Patients with overt CS at the time of enrolment will be followed for 12 months after remission (with re-evaluations after 6 and 12 months). At each visit, patients will undergo transthoracic echocardiography, cardiac magnetic resonance imaging, 24-h electrocardiogram, 24-h blood pressure measurement, and indirect evaluation of endothelial function. Furthermore, a standardised clinical investigation, an extensive biochemical workup, and a detailed assessment of quality of life and psychosocial status will be applied. Study results (e.g. cardiac morphology and function according to transthoracic echocardiography and cardiac magnetic resonance imaging; e.g. prevalence of CV risk factors) from patients with CS will be compared with matched controls without CS derived from two German population-based studies. Discussion: CV-CORT-EX is designed to provide a comprehensive overview of the health status of patients with endogenous CS, mainly focussing on CV aspects, and the holistic changes following remission.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Symptomatic vs. asymptomatic urothelial carcinoma in Germany: 39-months follow-up data from the non-interventional; prospective VERSUS study by d-uo
    Eichenauer, Rolf Harald
    Johannsen, Manfred
    Klier, Joerg
    Koenig, Frank
    Schoenfelder, Robert
    Schroeder, Joerg
    Hempel, Elke
    Doehn, Christian
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 108 - 108
  • [32] Symptomatic vs. asymptomatic urothelial carcinoma in Germany: 32-months follow-up data from the non-interventional, prospective VERSUS study by d-uo
    Eichenauer, R.
    Johannsen, M.
    Schoenfelder, R.
    Klier, J.
    Koenig, F.
    Schroeder, J.
    Hempel, E.
    Doehn, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 75 - 75
  • [33] An Observational Follow-Up Study of Patients Previously Enrolled in Exubera Controlled Clinical Trials (FUSE): Design and Rationale
    Gatto, Nicolle M.
    Koralek, Daniel O.
    Lem, Joanna
    Jackson, Neville
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S38 - S38
  • [34] Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
    Alexander T. Cohen
    Cihan Ay
    Philippe Hainaut
    Hervé Décousus
    Ulrich Hoffmann
    Sean Gaine
    Michiel Coppens
    Pedro Marques da Silva
    David Jiménez
    Beatrice Amann-Vesti
    Bernd Brüggenjürgen
    Pierre Levy
    Julio Lopez Bastida
    Eric Vicaut
    Petra Laeis
    Eva-Maria Fronk
    Wolfgang Zierhut
    Thomas Malzer
    Peter Bramlage
    Giancarlo Agnelli
    Thrombosis Journal, 16
  • [35] Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
    Cohen, Alexander T.
    Ay, Cihan
    Hainaut, Philippe
    Decousus, Herve
    Hoffmann, Ulrich
    Gaine, Sean
    Coppens, Michiel
    da Silva, Pedro Marques
    Jimenez Castro, David
    Amann-Vesti, Beatrice
    Brueggenjuergen, Bernd
    Levy, Pierre
    Lopez Bastida, Julio
    Vicaut, Eric
    Laeis, Petra
    Fronk, Eva-Maria
    Zierhut, Wolfgang
    Malzer, Thomas
    Bramlage, Peter
    Agnelli, Giancarlo
    THROMBOSIS JOURNAL, 2018, 16
  • [36] Understanding disease burden, unmet needs, treatment pathways and outcomes of patients with hidradenitis suppurativa in England: Rationale and design of a retrospective, non-interventional study
    Ingram, John
    Shams, Kave
    Rashidghamat, Ellie
    Brown, Annette
    Pamies, Paula
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 93 - 94
  • [37] Design and rationale of the PROSPECTive evaluation of nivolumab in adjuvant esophageal cancer/gastroesophageal junction cancer (EC/GEJC) (PROSPECT-ESO): A prospective, non-interventional, multicentre cohort study
    Shah, M. A.
    Saeed, A.
    Kakehi, S.
    Kelly, R. J.
    Kondo, K.
    Herber, M.
    Stein, A.
    Khan, Z.
    Sestak, I.
    Halchenko, Y.
    Davis, C.
    Singh, P.
    ANNALS OF ONCOLOGY, 2024, 35 : S200 - S200
  • [38] Prospective long-term follow-up analysis of the cardiovascular system in marathon runners: study design of the Pro-MagIC study
    Schoenfeld, Julia
    Schindler, Michael Johannes
    Haller, Bernhard
    Holdenrieder, Stefan
    Nieman, David Christopher
    Halle, Martin
    La Gerche, Andre
    Scherr, Johannes
    BMJ OPEN SPORT & EXERCISE MEDICINE, 2020, 6 (01):
  • [39] Symptomatic vs. asymptomatic renal cell carcinoma in Germany: 32-months follow-up data from the non-interventional, prospective VERSUS study by d-uo
    Johannsen, M.
    Klier, J.
    Eichenauer, R.
    Schoenfelder, R.
    Koenig, F.
    Schroeder, J.
    Hempel, E.
    Doehn, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 23 - 24
  • [40] Mortality and cardiovascular morbidity in Type 1 diabetic patients with nephropathy - 10 years prospective follow-up study
    Astrup, AS
    Tarnow, L
    Pietraszek, L
    Parving, HH
    DIABETOLOGIA, 2004, 47 : A62 - A62